Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. The company is headquartered in Bad Homburg, Hessen and currently employs 176,207 full-time employees. The firm has operationally managed divisions Fresenius Kabi and Fresenius Helios as well as the holdings Fresenius Vamed and Fresenius Medical Care. Fresenius Kabi offers healthcare products for critically and chronically ill patients and offers essential medicines and medical technology for infusion, transfusion and clinical nutrition and its product portfolio includes intravenously administered generic medicines, infusion therapies and clinical nutrition. Fresenius Helios is a private hospital operator that operates clinics, medical facilities, rehabilitation centers and others. Fresenius Vamed provides services for hospitals and other healthcare facilities such as prevention, construction, service and operational management. Fresenius Medical Care offers products and services along the dialysis value chain and is a supplier of dialysis products such as dialysis machines, dialyzers and associated disposable accessories.
Follow-Up Questions
FSNUY 주식의 가격 성능은 어떻습니까?
FSNUY의 현재 가격은 $13.95이며, 전 거래일에 decreased 0% 하였습니다.
Fresenius SE & Co KGaA의 주요 사업 주제나 업종은 무엇입니까?
Fresenius SE & Co KGaA은 Health Care 업종에 속하며, 해당 부문은 Health Care입니다
Fresenius SE & Co KGaA의 시가총액은 얼마입니까?
Fresenius SE & Co KGaA의 현재 시가총액은 $31.4B입니다
Fresenius SE & Co KGaA는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 21명의 분석가가 Fresenius SE & Co KGaA에 대한 분석 평가를 실시했으며, 이는 9명의 강력한 매수, 11명의 매수, 3명의 보유, 0명의 매도, 그리고 9명의 강력한 매도를 포함합니다